Why is coronary heart disease of uraemic patients so frequent and so devastating?

被引：34

作者：

Amann, K

Ritz, C

Adamczak, M

Ritz, E

机构：

[1] Heidelberg Univ, Dept Internal Med, D-69115 Heidelberg, Germany

[2] Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany

[3] Med Univ Silesia, Dept Nephrol Endocrinol & Metab Dis, Katowice, Poland

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2003年 / 18卷 / 04期

关键词：

D O I：

10.1093/ndt/gfg059

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：631 / 640

页数：10

共 85 条

[81]

Yusuf S, 2000, NEW ENGL J MED, V342, P145

[82] Inflammation enhances cardiovascular risk and mortality in hemodialysis patients [J].

Zimmermann, J ;

Herrlinger, S ;

Pruy, A ;

Metzger, T ;

Wanner, C .

KIDNEY INTERNATIONAL, 1999, 55 (02) :648-658

[83] Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease:: a prospective study [J].

Zoccali, C ;

Bode-Böger, SM ;

Mallamaci, F ;

Benedetto, FA ;

Tripepi, G ;

Malatino, LS ;

Cataliotti, A ;

Bellanuova, I ;

Fermo, I ;

Frölich, JC ;

Böger, RH .

LANCET, 2001, 358 (9299) :2113-2117

[84]

Zoccali C, 2002, J AM SOC NEPHROL, V13, P490, DOI 10.1681/ASN.V132490

[85] Nephrologists neglect administration of betablockers to dialysed diabetic patients [J].

Zuanetti, G ;

Maggioni, AP ;

Keane, W ;

Ritz, E .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (12) :2497-2500

← 1 2 3 4 5 6 7 8 9 →